MiRNA inhibits the apoptosis of ovarian cancer cells mainly through inhibition of the death receptor pathway, inhibition of the mitochondrial apoptosis pathway, and activation of the PI3K/AKT pathway. Here, AKT1 is linked to ovarian carcinoma.